MACQUARIE GROUP LTD - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,821,000
-51.1%
1,732,292
-11.2%
0.05%
-46.2%
Q2 2023$79,366,000
-0.3%
1,951,453
+18.8%
0.09%
-4.2%
Q1 2023$79,594,000
+33.1%
1,643,150
+4.9%
0.10%
+33.8%
Q4 2022$59,800,000
-23.8%
1,566,680
+0.3%
0.07%
-26.0%
Q3 2022$78,462,000
+16.0%
1,562,218
-7.5%
0.10%
+26.3%
Q2 2022$67,650,000
+16.8%
1,688,734
+8.7%
0.08%
+72.7%
Q1 2022$57,940,000
-4.5%
1,552,928
+2.0%
0.04%
-13.7%
Q4 2021$60,654,000
+3.7%
1,522,827
-3.1%
0.05%
+2.0%
Q3 2021$58,473,000
+10.2%
1,571,441
+25.2%
0.05%
+13.6%
Q2 2021$53,075,000
-2.4%
1,255,616
+9.3%
0.04%
-42.9%
Q1 2021$54,395,000
-15.1%
1,148,781
+9.5%
0.08%
-18.1%
Q4 2020$64,045,000
+43.9%
1,049,407
+10.2%
0.09%
+25.3%
Q3 2020$44,515,000
-6.1%
952,178
+2.0%
0.08%
-8.5%
Q2 2020$47,388,000
+32.5%
933,938
+16.5%
0.08%
+12.3%
Q1 2020$35,764,000
+83.1%
801,697
+97.2%
0.07%
+160.7%
Q4 2019$19,528,000
+278871.4%
406,569
+203184.5%
0.03%
Q2 2018$7,000
-30.0%
200
-66.7%
0.00%
Q4 2017$10,000
-90.2%
600
-88.2%
0.00%
Q3 2017$102,000
-61.1%
5,100
-87.5%
0.00%
-100.0%
Q1 2016$262,000
-79.6%
40,643
+2.3%
0.00%
-66.7%
Q4 2015$1,287,000
+15.8%
39,710
-4.5%
0.00%
+50.0%
Q3 2015$1,111,000
-41.8%
41,595
+4.9%
0.00%
-50.0%
Q2 2015$1,909,000
-13.7%
39,668
+9.0%
0.00%0.0%
Q1 2015$2,213,000
-0.4%
36,376
-15.3%
0.00%
-20.0%
Q4 2014$2,222,000
+50.1%
42,926
+27.7%
0.01%
+66.7%
Q3 2014$1,480,00033,6190.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders